How to Buy Sonnet Biotherapeutics Holdings Stock
Sonnet Biotherapeutics Holdings Inc
Sonnet BioTherapeutics Holdings, Inc. , a clinical stage oncology-focused biotechnology company, develops platform for biologic medicines of single or bispecific action.
Sonnet Biotherapeutics Holdings stock last closed at $1.30, up 3.17% from the previous day, and has decreased 90.41% in one year. It has underperformed other stocks in the Biotechnology industry by 0.13 percentage points. Sonnet Biotherapeutics Holdings stock is currently +18.18% from its 52-week low of $1.10, and -91.88% from its 52-week high of $16.00.
At the moment, there are 3.07M shares of SONN outstanding. The market value of SONN is $3.99M. In the last 24 hours, 30,053 SONN shares were traded.
How to Buy Sonnet Biotherapeutics Holdings Stock
Not sure how to invest in Sonnet Biotherapeutics Holdings stock? Here's how.
- Decide where to buy Sonnet Biotherapeutics Holdings stock: You need to choose a stock brokerage, but don't worry - we've tried dozens of online brokerages and apps to help you determine where to buy Sonnet Biotherapeutics Holdings stock.
- Open a brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've identified.
- Fund your brokerage account: Pick your method of payment and add your information.
- Research Sonnet Biotherapeutics Holdings stock: The Sonnet Biotherapeutics Holdings ticker symbol is SONN. Is Sonnet Biotherapeutics Holdings stock a good investment? Should you buy shares of SONN? How do SONN's underlying business fundamentals look? Do top analysts think Sonnet Biotherapeutics Holdings is a good buy? Why has SONN's stock price moved recently? (Hint: Our stock research tools can help you decide if SONN is a good stock to buy).
- Place your SONN purchase: Decide if you will purchase SONN shares at the current market price or use a limit order to purchase SONN stock at a particular price.
- Get the latest news on your SONN investment: Create a watchlist to keep tabs on your position in Sonnet Biotherapeutics Holdings stock.
Step 1: Decide where to buy Sonnet Biotherapeutics Holdings stock
You need an online brokerage account in order to access the NASDAQ market and buy SONN stock.
Our favorite brokerage: eToro
Based on our analysis, eToro is the best place to buy stocks. Here's why:
- Invest in stocks with 0% commissions: Invest without paying trading commissions.
- Buy fractional shares: Even if you can't afford a full share, you can still buy the stock.
- Access to world markets: From Technology to Real Estate, New York to Shanghai (for US users, only US stocks are available) — you can fill your portfolio with stocks from the world's top stock exchanges.
- Social investing: eToro offers a community of more than 20 million users worldwide. Talk to, learn from, and copy the crypto trades of other investors.
- Security: eToro is a regulated and licensed brokerage platform.
- Buy other assets: Such as ETFs and cryptos.
Get $10 towards your purchase of shares by creating an account with eToro now. This offer is only for US users.
Open eToro AccountStep 2: Open a brokerage account
Now that you've picked your brokerage, it's time to fill out some personal info so you are able to buy SONN stock today.
How to Start a New Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Enter your personal data to open a new trading account.
- Submit your information by clicking the "Create Account" button. Get started with eToro today
Step 3: Fund your brokerage account
Now that you have opened your account on the best stock buying app, you need to deposit funds:
Check out the walkthrough below for more details depositing money into your new investment account.
Step 4: Research Sonnet Biotherapeutics Holdings stock
Once you have identified the best place to buy Sonnet Biotherapeutics Holdings stock, it's critical to evaluate their stock before you invest, so you truly comprehend the risk and opportunity.
Sonnet Biotherapeutics Holdings quick stats
Sonnet Biotherapeutics Holdings Fundamentals
WallStreetZen was created to help part-time investors do more accurate fundamental analysis in minutes instead of hours.
You can view all of the due diligence checks on SONN's stock page.
Is SONN stock properly valued?
You can use many financial metrics, analyses, models, and charts to gauge SONN's true value.
Using relative valuations metrics:
- SONN may be undervalued based on its P/B ratio of 0.99x, relative to Biotechnology industry P/B ratio of 4.04x
You can do additional valuation research on SONN's stock here.
How do SONN Financials look?
Passed Health Checks:
- There are more short-term assets than long-term liabilities on the SONN balance sheet.
- There are more short-term assets than short-term liabilities on the SONN balance sheet.
- SONN has $4.86M in cash and short term investments. This is sufficient to cover its annual cash burn of $8.43M.
- Total SONN debt is lower than 5 years ago, relative to shareholder equity.
Failed Health Checks:
- SONN has a relatively high debt to equity ratio of 0.78.
- SONN profit margin has gone up by 102.5 percentage points in the past year, but the company is still unprofitable.
- SONN has cash burn of 8426232. It does not have enough cash and short-term investments to cover this.
Do analysts think it's a good time to buy SONN stock
Out of 1 sell side analysts who track SONN, the consensus analyst rating on Sonnet Biotherapeutics Holdings is a Strong Buy
Please keep in mind that analyst forecasts are not stock recommendations, nor are they investment advice.
You can dive deeper into what analysts are saying on the Sonnet Biotherapeutics Holdings stock forecast page.
Metrics for Advanced SONN Traders
SONN Revenue
Last year, SONN revenue was $1.00M. Over the last five year, SONN's revenue has grown by -33.75% per year. This was slower than the Biotechnology industry average of 44.31%.
Dig into SONN's earnings and revenue performance here.
Are SONN executives and large shareholders buying or selling the stock?
In the last year, insiders at SONN have not bought or sold any shares.
Dig into more about who owns SONN shares here.
Does SONN stock generate passive income?
No, Sonnet Biotherapeutics Holdings doesn't provide an income stream by paying out dividends.
What others are saying about SONN
One of the reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to see what other community members have to say.
Step 5: Place your SONN purchase
You have two primary options:
- Market order: A market order is an order to buy or sell a stock at the best possible price.
Market orders are usually the easiest way to buy. - Limit order: A limit order lets you buy or sell a stock at a specific price (or better).
If you want to be sure you're buying or selling at an exact price, use a limit order.
Press the Open button and eToro will execute the order.
If you require more help with investing in stocks on eToro, click the how to video below:
Step 6: Get the latest news on your SONN investment
Now that you own some shares in SONN, you'll want to keep up with your new investment.
Put SONN on a watchlist to get alerted to the latest events about your SONN stock.
SONN Feed
How to Buy Stock in Sonnet Biotherapeutics Holdings
To reiterate, here are the 6 steps to buy Sonnet Biotherapeutics Holdings stock:
- Decide where to buy Sonnet Biotherapeutics Holdings stock
- Open a brokerage account
- Fund your brokerage account
- Research Sonnet Biotherapeutics Holdings stock
- Place your SONN purchase
- Get the latest news on your SONN investment
If you are looking for a online brokerage, eToro is our recommended option.
Get Started with eToro TodayIf you would like to keep an eye on your new investment in Sonnet Biotherapeutics Holdings, create a watchlist today.
Related Stock Buying Guides
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.